Your browser doesn't support javascript.
loading
Measurement of Cognitive Function in Exercise Oncology Studies in Patients Treated With Chemotherapy: A Scoping Review.
Moon, Crisann; Wilson, Rebekah L; Gonzalo-Encabo, Paola; Kang, Dong-Woo; Mithani, Sara; Dieli-Conwright, Christina M; Patel, Darpan I.
Afiliación
  • Moon C; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Wilson RL; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gonzalo-Encabo P; Harvard Medical School, Boston, MA, USA.
  • Kang DW; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mithani S; Harvard Medical School, Boston, MA, USA.
  • Dieli-Conwright CM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Patel DI; Harvard Medical School, Boston, MA, USA.
Integr Cancer Ther ; 23: 15347354241265349, 2024.
Article en En | MEDLINE | ID: mdl-39045709
ABSTRACT
Cancer-associated cognitive deficits following chemotherapy have received increased attention in clinical research. Exercise has been shown to preserve cognitive function in cancer patients, though the overall effect is mixed. Here we present a scoping review of the published literature summarizing methods used to assess cognitive function in exercise oncology trials.

Methods:

PubMed, PsycINFO and CINAHL databases were searched using keywords "cognition," "cancer" OR "neoplasm" OR "tumor," "chemotherapy" and "exercise" OR "physical activity." Studies eligible for inclusion include prospective studies that were published in English in peer-reviewed journals that include a method of assessing cognitive function in adult cancer patients, in which an exercise modality or method of quantifying exercise habits was evident. Studies were excluded if they included a pediatric population, patients that were not diagnosed with cancer, or were systematic/narrative/scoping reviews, protocol papers or dissertation/theses.

Results:

A total of 29 studies met the inclusion criteria. In total, 29 unique assessments were used to evaluate cognitive function, including patient-reported outcomes (PROs; n = 8) and objective (n = 21) methods. More than half (n = 17) of included studies relied on PROs while 12 studies utilized objective measures of cognitive function Cognitive domains of the PROs were limited in scope, focusing on memory and attention/concentration while the objective measures were broader and inclusive of multiple domains.

Conclusion:

The results of this review indicate that mixed approaches to evaluating cognitive function in cancer patients pose a major limitation to understanding the role of exercise as an integrative approach. The evidence demonstrates a need for more uniform assessment of cognitive function in exercise oncology trials.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ejercicio Físico / Cognición / Neoplasias Límite: Humans Idioma: En Revista: Integr Cancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ejercicio Físico / Cognición / Neoplasias Límite: Humans Idioma: En Revista: Integr Cancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos